BioSpace News Archive

Business

Cipher Pharmaceuticals Reports Q3 2018 Results

Canadian product revenue increased 27%

November 7, 2018
·
14 min read
Biotech Beach

Ionis Pharmaceuticals to Present at Upcoming November and December 2018 Investor Conferences

Ionis Pharmaceuticals, Inc. today announced that management will present a company overview at the following investor conferences

November 7, 2018
·
3 min read
Biotech Beach

Mirum Pharmaceuticals Secures $120 Million in Series A Financing to Develop Phase 3-Ready Maralixibat for Rare Liver Diseases

Maralixibat Phase 2b study interim analysis suggests proof of concept in Alagille syndrome

November 7, 2018
·
6 min read
Business

Compugen Reports Third Quarter 2018 Results

Compugen Ltd. today reported financial results for the third quarter ended September 30, 2018.

November 7, 2018
·
8 min read
Bausch Health Announces U.S. Launch Of BRYHALI™ (halobetasol propionate) Lotion, 0.01%, For Plaque Psoriasis In Adults

Launch Expected to Occur Later this Month Following Final FDA Approval

November 7, 2018
·
8 min read
Business

Sierra Oncology to Present at the Jefferies 2018 London Healthcare Conference

“Targeted Therapeutics for Hematology & Oncology” scheduled for 5:20 p.m. GMT on November 14, 2018

November 7, 2018
·
3 min read
Business

Alkahest Appoints Elizabeth Jeffords as Chief Commercial and Strategy Officer

Alkahest, Inc. today announced the appointment of Elizabeth Jeffords as chief commercial and strategy officer.

November 7, 2018
·
2 min read
Genetown

RXi Pharmaceuticals to Present New Data Demonstrating the Ability of sd-rxRNA to Enhance NK Cell Activity for Adoptive Cell Transfer at SITC 2018

RXi Pharmaceuticals Corporation will present a poster highlighting data demonstrating the potential of sd-rxRNA to improve NK cell potency in adoptive cell transfer (ACT) at SITC 2018, the 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC).

November 7, 2018
·
3 min read
Pharm Country

Bristol-Myers Squibb to Take Part in Credit Suisse 2018 Health Care Conference

Bristol-Myers Squibb Company will take part in the Credit Suisse Annual Health Care Conference on Wednesday, November 14, 2018 in Scottsdale, AZ. Chris Boerner, chief commercial officer, will answer questions about the company at 8 a.m. MT (10 a.m. ET).

November 7, 2018
·
1 min read
Alpha Tau Medical Launches New Clinical Trials in Italy with Leading Cancer Centers, La Sapienza and IFO

Trials will investigate the efficacy of its breakthrough cancer treatment, Alpha DaRT, in Squamous Cell Carcinoma (SCC) of the Skin, and Cutaneous and Mucosal malignant Neoplasia (CMN)

November 7, 2018
·
2 min read